Encompass Health Co. (NYSE:EHC) Stake Raised by Atom Investors LP

Atom Investors LP lifted its holdings in Encompass Health Co. (NYSE:EHC) by 460.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 40,829 shares of the company’s stock after purchasing an additional 33,544 shares during the quarter. Atom Investors LP’s holdings in Encompass Health were worth $3,946,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Virtu Financial LLC bought a new stake in Encompass Health during the first quarter worth approximately $208,000. Cetera Advisors LLC bought a new stake in shares of Encompass Health in the 1st quarter worth $291,000. GAMMA Investing LLC lifted its holdings in shares of Encompass Health by 92.2% in the second quarter. GAMMA Investing LLC now owns 1,184 shares of the company’s stock valued at $102,000 after buying an additional 568 shares during the period. Harbor Capital Advisors Inc. grew its holdings in Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after acquiring an additional 26,270 shares during the period. Finally, CWM LLC raised its position in Encompass Health by 6.3% in the second quarter. CWM LLC now owns 6,388 shares of the company’s stock worth $548,000 after acquiring an additional 379 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

Shares of EHC opened at $102.94 on Monday. The firm has a market cap of $10.37 billion, a PE ratio of 24.86, a PEG ratio of 1.36 and a beta of 0.88. The firm’s 50 day moving average price is $98.16 and its 200 day moving average price is $91.42. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s revenue was up 11.9% compared to the same quarter last year. During the same period last year, the company earned $0.86 earnings per share. As a group, research analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.66%. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Analyst Ratings Changes

A number of analysts recently weighed in on EHC shares. Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. KeyCorp increased their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Stephens restated an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, UBS Group upped their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.